Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

32.43
-0.0289-0.09%
Post-market: 32.450.0189+0.06%19:30 EDT
Volume:4K
Turnover:120.89K
Market Cap:41.35M
PE:- -
High:32.54
Open:32.54
Low:32.29
Close:32.46
52wk High:35.61
52wk Low:27.50
Shares:1.28M
Float Shares:1.28M
Volume Ratio:1.09
T/O Rate:0.29%
Dividend:0.08
Dividend Rate:0.23%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

TIPRANKS
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Sep 18

All 50 States Sign up for Trump's Medicaid Most-Favored-Nation Plan

Reuters
·
Sep 18

When Weight Loss Isn't the Goal of Taking a GLP-1

Dow Jones
·
Sep 18

InfuSystem to Host Investor Webcast on Strategy

TIPRANKS
·
Sep 18

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 18

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
Sep 18

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 18

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
Sep 18

Wolfe Research Initiates Rhythm Pharmaceuticals at Outperform

MT Newswires Live
·
Sep 17

Goldman Sachs Adjusts Eli Lilly Price Target to $1,371 From $1,367, Maintains Buy Rating

MT Newswires Live
·
Sep 17

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

TIPRANKS
·
Sep 17

Rhythm Pharmaceuticals initiated with an Outperform at Wolfe Research

TIPRANKS
·
Sep 17

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

TIPRANKS
·
Sep 17

GenScript Biotech Hits Near 5-Year High on Eli Lilly Collaboration

Reuters
·
Sep 17

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock

Reuters
·
Sep 17

Legend Biotech CEO Ingrid Zhang Files Initial Beneficial Ownership Statement

Reuters
·
Sep 17

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16

Sector Update: Healthcare

MT Newswires Live
·
Sep 16

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS
·
Sep 16